Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I / II Multicentre, Randomized and Controlled Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection

NCT04366245 is registered in ClinicalTrials.gov with Andalusian Network for Design and Translation of Advanced Therapies as lead sponsor.

NCT NCT04366245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04366245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I / II Multicentre, Randomized and Controlled Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
Lead sponsor
Andalusian Network for Design and Translation of Advanced Therapies
Phase
Phase 1/2
Overall status
Completed
Start date
April 23, 2020
Completion date
December 30, 2020
Enrollment
72 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov 2